Israeli cannabis company Tikun-Olam Cannabit has signed a partnership with Ambrosia-SupHerb to produce and market nutritional supplements based on cannabis and mushrooms. Ambrosia-SupHerb is Israel’s largest nutritional supplement manufacturer and is engaged in the production of nutritional supplements and is the marketer of Solgar’s nutritional supplements in Israel.
As part of the partnership, a pilot will be launched, led by the companies’ research and development teams to develop the products, including combining components of additional nutritional supplements such as vitamins, minerals, amino acids, and plants. The companies applied to the Medical Cannabis Unit after signing the agreement to receive approval for the research and development activity in Israel.
Avinoam Sapir, general manager for Tikun Olam-Cannbit, said the market has “tremendous sales potential,” noting that the company has “seen the mushroom market flourishing in the East and growing in the U.S.”
“We view the combined power of empirical research and extraction expertise that we have along with the product development and shipping abilities of SupHerb in the nutritional supplement market in Israel and worldwide as perfect synergy. … Our empirical knowledge in the field of medical cannabis brings added value in creation of an innovative product that heralds a new message for patients worldwide.” – Sapir in a press release
Eitan Markovits, CEO and owner of Ambrosia SupHerb Group, called the partnership “groundbreaking” and that the partnership “will introduce the added value, professionalism and experience [SubHerb has] accrued over our 35 years of activity into the new worlds of cannabis-based nutritional supplements.”
The project marks the first time that an Israeli company will develop nutritional supplements based on cannabis and mushrooms.
Exclusive offer from our sponsor:
Get daily news insights in your inbox. Subscribe